Mark T. Miedel

University of Pittsburgh

NIH Rank #4973
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.1M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#4,973
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.1M across 3 grants · National rank #4973.

Top grants by award amount

Mark T. Miedel's NIH grant portfolio, ranked by award amount.

  • 1U2CTR004863-01U2C
    Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
    $1.1M
    award amount
  • 1R01DK135606-01A1R01
    Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
    $695.6K
    award amount
  • 4UH3TR004124-03UH3
    Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
    $238.5K
    award amount

Affiliation

Institutions that have administered grants for Mark T. Miedel.

Affiliated with University of Pittsburgh (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4973
  6. 2024
    Entered Top 25% Nationally
    Ranked #4973